BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2457482)

  • 1. [IPO-10 monoclonal antibodies to the human B-lymphocyte differentiation antigen].
    Sidorenko SP; Vetrova EP; Berdova AG; Shlapatskaia LN; Evsev'eva AI
    Eksp Onkol; 1988; 10(3):42-4. PubMed ID: 2457482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies IPO-3 and IPO-10 against human B cell differentiation antigens.
    Pinchouk VG; Sidorenko SP; Gluzman DF; Vetrova EP; Berdova AG; Schlapatskaya LN
    Anticancer Res; 1988; 8(6):1377-80. PubMed ID: 3265315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Monoclonal antibodies to RPMI-1788 lymphoblastoid line cells].
    Pinchuk VG; Sidorenko SP; Vetrova EP; Berdova AG; Shlapatskaia LN
    Eksp Onkol; 1986; 8(6):41-6. PubMed ID: 3026773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies of IPO series against B cell differentiation antigens in leukemia and lymphoma immunophenotyping.
    Sidorenko SP; Vetrova EP; Yurchenko OV; Berdova AG; Shlapatskaya LN; Gluzman DF
    Neoplasma; 1992; 39(1):3-9. PubMed ID: 1528302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monoclonal antibodies IPO-4 recognizing antigen-activated human T and B lymphocytes].
    Sidorenko SP; Berdova AG; Vetrova EP; Shlapatskaia LN; Iurchenko OV; Evsev'eva AI; Gluzman DF
    Eksp Onkol; 1990; 12(3):21-4. PubMed ID: 2344819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SC3 monoclonal antibody defines a novel specific human B-cell surface antigen differentially expressed on B-cell leukaemias and lymphomas and involved in the proliferation of normal and malignant B lymphocytes.
    Nikolova M; Guenova M; Taskov H; Marie-Cardine A; Boumsell L; Bensussan A
    Cell Immunol; 2005; 236(1-2):92-100. PubMed ID: 16197933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of functional domain structures on human DR determinants with mouse hybridoma antibody Tyn B1].
    Nagayoshi T
    Fukuoka Igaku Zasshi; 1985 Jun; 76(6):306-16. PubMed ID: 2414196
    [No Abstract]   [Full Text] [Related]  

  • 8. [The expression of an antigen interacting with monoclonal antibody IB4 on the surface membranes of normal human leukocytes and in lymphoproliferative diseases].
    Filatov AV; Bachurin PS; Sidorenko SP; Abramenko IV; Gluzman DF
    Eksp Onkol; 1990; 12(5):40-3. PubMed ID: 2226257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of I region-restricted, antigen-specific T cell hybridomas to produce idiotypically specific anti-receptor antibodies.
    White J; Haskins KM; Marrack P; Kappler J
    J Immunol; 1983 Mar; 130(3):1033-7. PubMed ID: 6185566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
    Tong AW; Lee J; Stone MJ
    Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional studies on B cell hybridomas with B cell surface antigens. II. Ia molecules on the cell membrane and the differentiative response to anti-mu antibody.
    Hamano T; Leiserson WM; Asofsky R
    J Immunol; 1983 Jul; 131(1):98-102. PubMed ID: 6408183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B5, a new B cell-restricted activation antigen.
    Freedman AS; Boyd AW; Anderson KC; Fisher DC; Schlossman SF; Nadler LM
    J Immunol; 1985 Apr; 134(4):2228-35. PubMed ID: 2579134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monoclonal antibodies to the antigens of human HeLa tumor cells].
    Malakhova IV; Khizhniakova TM; Novokhatskiĭ AS
    Tsitologiia; 1986 May; 28(5):537-44. PubMed ID: 3526672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downmodulation of antigen presentation by H2-O in B cell lines and primary B lymphocytes.
    Brocke P; Armandola E; Garbi N; Hämmerling GJ
    Eur J Immunol; 2003 Feb; 33(2):411-21. PubMed ID: 12645938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and characterization of monoclonal antibodies recognizing the alpha-chain subunits of human ia alloantigens.
    Adams TE; Bodmer JG; Bodmer WF
    Immunology; 1983 Dec; 50(4):613-24. PubMed ID: 6197354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of monoclonal antibodies recognizing three distinct differentiation antigens (BL1, BL2, BL3) on human B lymphocytes.
    Wang CY; Azzo W; Al-Katib A; Chiorazzi N; Knowles DM
    J Immunol; 1984 Aug; 133(2):684-91. PubMed ID: 6429242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A monoclonal antibody with reactivity restricted to normal and neoplastic plasma cells.
    Anderson KC; Bates MP; Slaughenhoupt B; Schlossman SF; Nadler LM
    J Immunol; 1984 Jun; 132(6):3172-9. PubMed ID: 6427334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies.
    Quackenbush EJ; Letarte M
    J Immunol; 1985 Feb; 134(2):1276-85. PubMed ID: 3155538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies to human lung tumor antigens demonstrated by immunofluorescence and immunoprecipitation.
    Brenner BG; Jothy S; Shuster J; Fuks A
    Cancer Res; 1982 Aug; 42(8):3187-92. PubMed ID: 7046919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.